BPI-371153

BPI-371153 · Betta Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BPI-371153, covering 2025-01-27 to 2025-01-27. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of BPI-371153 in Subjects with Advanced Solid Tumors or Relapsed/Refractory Lymphoma [Phase 1]